Annual Revenue
$1.63 M
+$333.00 K+25.60%
December 31, 2023
Summary
- As of February 7, 2025, INBX annual revenue is $1.63 million, with the most recent change of +$333.00 thousand (+25.60%) on December 31, 2023.
- During the last 3 years, INBX annual revenue has fallen by -$11.17 million (-87.24%).
- INBX annual revenue is now -87.24% below its all-time high of $12.81 million, reached on December 31, 2020.
Performance
INBX Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Revenue
N/A
September 30, 2024
Summary
- INBX quarterly revenue is not available.
Performance
INBX Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Related metrics
TTM Revenue
N/A
September 30, 2024
Summary
- INBX TTM revenue is not available.
Performance
INBX TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
INBX Revenue Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +25.6% | - | - |
| 3 y3 years | -87.2% | - | - |
| 5 y5 years | -78.2% | - | - |
INBX Revenue Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -77.1% | +25.6% | ||||
| 5 y | 5-year | -87.2% | +25.6% | ||||
| alltime | all time | -87.2% | +25.6% |
Inhibrx Biosciences Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2024 | - | $100.00 K(-93.2%) | $1.69 M(+3.2%) |
| Dec 2023 | $1.63 M(+25.6%) | $1.47 M(+1133.6%) | $1.63 M(+271.4%) |
| Sep 2023 | - | $119.00 K(+296.7%) | $440.00 K(-26.5%) |
| Jun 2023 | - | $30.00 K(+76.5%) | $599.00 K(-53.2%) |
| Mar 2023 | - | $17.00 K(-93.8%) | $1.28 M(-41.2%) |
| Dec 2022 | $1.30 M(-81.7%) | $274.00 K(-1.4%) | $2.18 M(-54.1%) |
| Sep 2022 | - | $278.00 K(-60.9%) | $4.74 M(-32.0%) |
| Jun 2022 | - | $711.00 K(-22.3%) | $6.97 M(-2.9%) |
| Mar 2022 | - | $915.00 K(-67.7%) | $7.18 M(+0.7%) |
| Dec 2021 | $7.13 M | $2.84 M(+13.1%) | $7.13 M(+0.8%) |
| Sep 2021 | - | $2.51 M(+173.2%) | $7.07 M(-32.0%) |
| Jun 2021 | - | $918.00 K(+6.4%) | $10.38 M(-18.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | $863.00 K(-68.9%) | $12.80 M(-0.1%) |
| Dec 2020 | $12.81 M(+40.9%) | $2.78 M(-52.4%) | $12.81 M(+24.4%) |
| Sep 2020 | - | $5.83 M(+74.7%) | $10.30 M(+95.5%) |
| Jun 2020 | - | $3.33 M(+282.3%) | $5.27 M(+79.6%) |
| Mar 2020 | - | $872.00 K(+226.6%) | $2.93 M(-67.7%) |
| Dec 2019 | $9.09 M(+21.2%) | $267.00 K(-66.4%) | $9.09 M(+3.0%) |
| Sep 2019 | - | $794.00 K(-20.6%) | $8.83 M(+9.9%) |
| Jun 2019 | - | $1.00 M(-85.8%) | $8.03 M(-15.7%) |
| Mar 2019 | - | $7.03 M(+181.3%) | $9.53 M(+90.6%) |
| Dec 2018 | $7.50 M(-5.7%) | - | - |
| Jun 2018 | - | $2.50 M(0.0%) | $5.00 M(+100.0%) |
| Mar 2018 | - | $2.50 M | $2.50 M |
| Dec 2017 | $7.95 M | - | - |
FAQ
- What is Inhibrx Biosciences annual revenue?
- What is the all time high annual revenue for Inhibrx Biosciences?
- What is Inhibrx Biosciences annual revenue year-on-year change?
- What is the all time high quarterly revenue for Inhibrx Biosciences?
- What is the all time high TTM revenue for Inhibrx Biosciences?
What is Inhibrx Biosciences annual revenue?
The current annual revenue of INBX is $1.63 M
What is the all time high annual revenue for Inhibrx Biosciences?
Inhibrx Biosciences all-time high annual revenue is $12.81 M
What is Inhibrx Biosciences annual revenue year-on-year change?
Over the past year, INBX annual revenue has changed by +$333.00 K (+25.60%)
What is the all time high quarterly revenue for Inhibrx Biosciences?
Inhibrx Biosciences all-time high quarterly revenue is $7.03 M
What is the all time high TTM revenue for Inhibrx Biosciences?
Inhibrx Biosciences all-time high TTM revenue is $12.81 M